BENTONVILLE, Ark., Nov. 3, 2025 /PRNewswire/ -- HFA, an employee-owned, nationally recognized architecture and engineering firm, today announced the acquisition of…
In this free webinar, learn how crystallization strategies can optimize API development and scale-up. Attendees will understand the importance of…
Orchestrated by the NavaX Super Agent, the Suite includes previously launched MedDRA Coding Agent and upcoming cross-domain Agents BOSTON, Nov. 3,…
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- Partillion Bioscience today announced the launch of Developer Kits, a ready foundation for…
LOS ALTOS HILLS, CA / ACCESS Newswire / November 3, 2025 / Reprieve House has opened its doors as Silicon…
Bringing Next-Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions MESA, ARIZONA / ACCESS Newswire / November 3,…
- CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and…
Dr. Naderi reveals how younger generations are embracing prejuvenation with collagen-boosting treatments and skincare to maintain a natural, youthful glow…
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech…
Key Highlights:Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026…